Página 2 - U.S. Pharmaceuticals & Biotech Acciones - Principales ganancias de hoy

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

ACTUALIZADO Jun 13, 2026

Explore U.S. (NYSE y NASDAQ) Las mayores ganancias de hoy. Estos Pharmaceuticals & Biotech Stocks han visto el mayor aumento en la capitalización de mercado desde el día de negociación anterior.

712 empresas

Empresa	Último precio	1D Retorno	Rendimiento 1 año	Capitalización bursátil	Objetivo de los analistas	Valoración	Crecimiento	Div Rendimiento
AKTS	US$21.93	12.7%	n/a	US$1.2b	US$32.65	146.5	-25.1%	n/a
MDGL	US$480.77	1.4%	62.7%	US$11.1b	US$678.71	9.8	59.2%	n/a
ZBIO	US$19.80	11.5%	91.7%	US$1.3b	US$42.13	3.7	22.6%	n/a
INCY	US$108.53	0.6%	60.2%	US$21.7b	US$109.09	15.1	-15.3%	n/a
TWST	US$76.17	2.9%	127.2%	US$4.7b	US$66.67	11.6	39.0%	n/a
RLAY	US$14.81	4.0%	359.9%	US$3.2b	US$24.82	302.3	14.3%	n/a
CYTK	US$70.15	1.3%	104.0%	US$9.5b	US$104.70	90.0	51.9%	n/a
TRVI	US$14.21	5.6%	133.3%	US$2.0b	US$23.90	11.7	-6.5%	n/a
MRNA	US$49.91	0.5%	87.1%	US$19.8b	US$43.30	8.9	53.1%	n/a
CLDX	US$31.27	4.4%	47.1%	US$2.5b	US$57.53	2837.5	46.0%	n/a
DNLI	US$21.66	3.0%	48.9%	US$3.4b	US$33.93	3.7	37.9%	n/a
GLUE	US$18.24	6.6%	271.4%	US$1.5b	US$32.33	35.9	-10.5%	n/a
CRNX	US$34.47	2.8%	8.5%	US$3.6b	US$83.14	201.1	51.3%	n/a
EWTX	US$34.83	2.7%	127.8%	US$3.7b	US$46.08	7.6	25.0%	n/a
CMPS	US$12.08	5.9%	175.2%	US$1.6b	US$22.20	5.0	55.6%	n/a
SEPN	US$35.95	5.6%	253.5%	US$1.6b	US$45.78	22.4	-32.4%	n/a
AVLN	US$30.08	7.2%	n/a	US$1.3b	US$59.00	-14.8	-18.4%	n/a
TYRA	US$26.99	5.6%	158.8%	US$1.6b	US$51.60	4.1	-1.9%	n/a
ORKA	US$69.89	2.1%	456.4%	US$4.2b	US$142.17	8.7	-27.6%	n/a
COGT	US$33.10	1.5%	367.5%	US$5.7b	US$54.25	10.4	65.0%	n/a
A	US$129.84	0.2%	10.9%	US$36.7b	US$160.35	25.9	12.2%	0.8%
TEVA	US$34.63	0.2%	103.8%	US$40.3b	US$40.90	25.8	15.1%	0%
BMRN	US$55.95	0.7%	-0.5%	US$10.8b	US$87.85	40.2	24.7%	n/a
AMLX	US$14.59	4.9%	164.3%	US$1.6b	US$23.40	5.9	55.1%	n/a

Page 2 of 30